Postpartum cells derived from placental tissue, and methods of making and using the same
First Claim
Patent Images
1. A cell culture comprising an isolated homogeneous cell population and a culture medium, wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture;
- is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr-alpha, PD-L2 and HLA-A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin;
produces granulocyte chemotactic protein-2 (GCP-2); and
has the ability to undergo at least 40 population doublings in culture, and wherein the culture medium comprises Dulbecco'"'"'s modified Eagle'"'"'s medium (DMEM)-low glucose, DMEM-high glucose, RPMI1640, serum- and protein-free DMEM, DMEM/MCDB201, Ham'"'"'s F10 medium, Ham'"'"'s F12 medium, DMEM/F12, Iscove'"'"'s modified Dulbecco'"'"'s medium, or Eagle'"'"'s basal medium.
8 Assignments
0 Petitions
Accused Products
Abstract
Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
251 Citations
44 Claims
-
1. A cell culture comprising an isolated homogeneous cell population and a culture medium, wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture;
- is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr-alpha, PD-L2 and HLA-A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin;
produces granulocyte chemotactic protein-2 (GCP-2); and
has the ability to undergo at least 40 population doublings in culture, and wherein the culture medium comprises Dulbecco'"'"'s modified Eagle'"'"'s medium (DMEM)-low glucose, DMEM-high glucose, RPMI1640, serum- and protein-free DMEM, DMEM/MCDB201, Ham'"'"'s F10 medium, Ham'"'"'s F12 medium, DMEM/F12, Iscove'"'"'s modified Dulbecco'"'"'s medium, or Eagle'"'"'s basal medium. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
- is multipotent;
-
28. A cell culture comprising an isolated homogeneous cell population and a culture medium, wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture;
- is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr-alpha, PD-L2 and HLA-A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin;
produces granulocyte chemotactic protein-2 (GCP-2); and
has the ability to undergo at least 40 population doublings in culture.
- is multipotent;
-
29. A matrix comprising a cell culture,
wherein the matrix comprises a nonwoven scaffold comprising a copolymer of glycolic and lactic acids, a 35/65 PCL/PGA foam, an in situ polymerizable gel, or a self-assembling peptide hydrogel, and wherein the cell culture comprises an isolated homogeneous cell population and a culture medium, wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture; - is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr-alpha, PD-L2 and HLA-A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin; and
produces granulocyte chemotactic protein-2 (GCP-2). - View Dependent Claims (30, 31)
- is multipotent;
-
32. A kit comprising the cell culture comprising an isolated homogeneous cell population, a culture medium and at least one additional component selected from the group consisting of a scaffold, a hydrating agent, and a cell culture substrate, wherein the cell population is cryopreserved, and wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture;
- is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr- alpha, PD-L2 and HLA-A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin; and
produces granulocyte chemotactic protein-2 (GCP-2). - View Dependent Claims (33)
- is multipotent;
-
34. A cryopreserved composition comprising an isolated homogeneous cell population, wherein said isolated cell population is obtained from human postpartum placenta substantially free of blood, wherein said cell population self-renews and expands in culture;
- is multipotent;
produces CD10, CD13, CD44, CD73, CD90, PDGFr-alpha, PD-L2 and HLA- A,B,C;
does not produce CD31, CD34, CD45, CD80, CD86, CD117, CD141, CD178, B7-H2, HLA-G or HLA-DR-DP,DQ;
expresses, relative to a human fibroblast, mesenchymal stem cell, or iliac crest bone marrow cell, increased levels of oxidized low density lipoprotein receptor 1 mRNA and renin;
produces granulocyte chemotactic protein-2 (GCP-2); and
has the ability to undergo at least 40 population doublings in culture. - View Dependent Claims (35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
- is multipotent;
Specification